Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue -, Pages 15921
Publisher
Springer Nature
Online
2017-06-30
DOI
10.1038/ncomms15921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idelalisib
- (2015) Arpita Shah et al. ANNALS OF PHARMACOTHERAPY
- Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit
- (2015) Jing Yang et al. CELL
- Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer
- (2015) Y. Yang et al. CLINICAL CANCER RESEARCH
- Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities
- (2015) B.-D. Wang et al. CLINICAL CANCER RESEARCH
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alternative splicing in cancer: implications for biology and therapy
- (2014) J Chen et al. ONCOGENE
- A Novel Model to Combine Clinical and Pathway-Based Transcriptomic Information for the Prognosis Prediction of Breast Cancer
- (2014) Sijia Huang et al. PLoS Computational Biology
- Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone
- (2014) Mary Nakazawa et al. Hormones & Cancer
- Minireview: The Molecular and Genomic Basis for Prostate Cancer Health Disparities
- (2013) Isaac J. Powell et al. MOLECULAR ENDOCRINOLOGY
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activation
- (2012) Niki Tzenaki et al. FASEB JOURNAL
- IsoformEx: isoform level gene expression estimation using weighted non-negative least squares from mRNA-Seq data
- (2011) Hyunsoo Kim et al. BMC BIOINFORMATICS
- Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production
- (2011) H Fukuda et al. BRITISH JOURNAL OF CANCER
- Present and Future of PI3K Pathway Inhibition in Cancer: Perspectives and Limitations
- (2011) E. Ciraolo et al. CURRENT MEDICINAL CHEMISTRY
- CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies
- (2011) Jorge J Castillo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors
- (2011) S Fransson et al. ONCOGENE
- PI3K Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
- (2011) D. A. Fruman et al. Cancer Discovery
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
- (2010) S. E. M. Herman et al. BLOOD
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
- (2010) C. J. David et al. GENES & DEVELOPMENT
- Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic Subunits
- (2010) Xinnong Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
- (2010) Alex Berndt et al. Nature Chemical Biology
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-tumor activity of splice-switching oligonucleotides
- (2010) John A. Bauman et al. NUCLEIC ACIDS RESEARCH
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- Alternative splicing and biological heterogeneity in prostate cancer
- (2009) Prabhakar Rajan et al. Nature Reviews Urology
- Explaining the Race Difference in Prostate Cancer Stage at Diagnosis
- (2008) B. A. Jones et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
- Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
- (2008) J. Wang et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Targeting the Phosphoinositide 3-Kinase Isoform p110 Impairs Growth and Survival in Neuroblastoma Cells
- (2008) D. Boller et al. CLINICAL CANCER RESEARCH
- Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
- (2008) Y. Hu et al. CLINICAL CANCER RESEARCH
- Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis
- (2008) Simon Evans et al. INTERNATIONAL JOURNAL OF CANCER
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression
- (2008) Aijing Sun et al. PROSTATE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started